Skip to content

    Corvus Pharmaceuticals (CRVS) stock price & financials

    View CRVS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+157.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$7.25M
    -$8.11M
    -$9.92M
    -$10.26M
    -$10.57M
    -45.7%
    -$12.22M
    -50.7%
    -$14.88M
    -49.9%
    -$19.30M
    -88.1%
    Weakening
    Net Profit
    -$40.22M
    -$12.11M
    $15.19M
    -$8.00M
    -$10.16M
    +74.7%
    -$12.32M
    -1.7%
    -$13.69M
    -190.1%
    -$17.96M
    -124.5%
    Weakening
    EPS
    $-0.60
    $0.21
    $-0.10
    $-0.12
    +80.0%
    $-0.15
    -171.4%
    $-0.19
    -90.0%
    Weakening
    Other Income
    -$32.96M
    $25.11M
    $2.26M
    $415.0K
    $1.19M
    -95.3%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$39.53M
    -$9.94M
    $15.73M
    -$7.61M
    -$9.83M
    +75.1%
    -$11.61M
    -16.9%
    -$13.09M
    -183.2%
    -$17.25M
    -126.7%
    Weakening
    MarginsOPM
    Tax
    0.0%
    0.0%
    ReturnsROIC
    9.1%
    2.7%
    -3.4%
    1.8%
    2.3%
    -74.7%
    2.8%
    +1.7%
    3.1%
    4.0%
    +124.5%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$39.20M$5.15M$16.45M$63.46M$13.16M$12.62M$8.74M$4.58M$18.91M
    Short-Term Investments
    Total Current Assets$115.59M$79.34M$45.34M$71.31M$43.66M$27.96M$54.41M$58.21M$220.97M
    Net PP&E$2.18M$3.79M$2.55M$3.64M$2.57M$1.39M$1.33M$1.06M$1.49M
    Goodwill
    Intangibles
    Total Assets$118.23M$83.65M$85.53M$109.45M$68.24M$45.55M$68.91M$71.12M$239.27M
    LiabilitiesTotal Current Liabilities$7.03M$10.22M$12.15M$9.69M$10.75M$6.87M$35.40M$9.38M$13.67M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$2.31M$1.23M$2.60M$1.37M$937.0K$534.0K$274.0K
    Total Liabilities$7.90M$12.54M$13.38M$12.29M$12.13M$6.87M$36.34M$9.91M$13.95M
    EquityCommon Stock & APIC$3.0K$3.0K$3.0K$5.0K$5.0K$5.0K$7.0K$7.0K$8.0K
    Retained Earnings-$170.47M-$217.15M-$223.14M-$266.38M-$307.69M-$334.72M-$397.01M-$412.29M-$443.94M
    Total Equity$110.34M$71.11M$72.15M$97.16M$56.12M$38.68M$32.57M$61.20M$225.33M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$40.99M-$37.32M-$34.78M-$36.72M-$27.02M-$23.93M-$25.42M-$32.80M-$44.53M
    Cash from Investing-$30.19M$3.25M$44.77M$21.56M-$23.28M$15.54M-$27.48M-$7.80M-$142.55M
    Cash from Financing$65.27M$24.0K$1.31M$62.16M$0$7.86M$49.03M$36.43M$191.29M
    SummaryCapital Expenditure-$355.0K-$25.0K-$76.0K-$5.0K-$269.0K-$34.0K-$174.0K-$698.0K
    Free Cash Flow-$41.34M-$37.35M-$34.85M-$36.72M-$27.29M-$23.97M-$32.97M-$45.23M
    FCF Margin

    Ratios